Pfizer Inc.· @pfizer · X·· 13 天前AI 评分12
AI 导读
当前列腺癌对传统激素治疗产生耐药时，需要新的治疗方法。 辉瑞研究人员正在研究EZH2，探索潜在重编程转移性前列腺癌治疗耐药的方法。 了解更多：https://on.pfizer.com/4hbgke2
正文
When prostate cancer becomes resistant to traditional hormone therapies, new treatment approaches are needed.
Pfizer researchers are studying EZH2 and exploring ways to potentially reprogram treatment resistance in metastatic prostate cancer.
Learn more: https://on.pfizer.com/4hbgke2
来源：Pfizer Inc. · x.com